LTGO Conversion Disclosure
Foresite Capital Management V, Llc · SEC Form 4 · Filed Aug 10, 2026
Conversion
Calculated transaction value
$0
Foresite Capital Management V, Llc 10% owner
LTGO
Transaction date
Aug 10, 2026
Public filing date
Aug 11, 2026
Filing lag
Filed 1 day later
LTGO daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Series A-2 Convertible Preferred Stock on Common Stock
- Quantity / price
- 3,117,664 shares @ $0
- SEC ownership
- Indirect
- Transaction code
- C
- Form
- 4
- Filing identifier
- 0001104659-26-093580
Filing cohort
Transactions in this filing
Showing 15 of 15
Trades
15
Issuers
1
Estimated value
$2.52M
Buys / sales
1 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Latigo Biotherapeutics, Inc. LTGO | Conversion | Aug 10, 2026 | $0 |
| Latigo Biotherapeutics, Inc. LTGO | Buy | Aug 10, 2026 | $2.52M |
| Latigo Biotherapeutics, Inc. LTGO | Conversion | Aug 10, 2026 | $0 |
| Latigo Biotherapeutics, Inc. LTGO | Conversion | Aug 10, 2026 | Not reported |
| Latigo Biotherapeutics, Inc. LTGO | Conversion | Aug 10, 2026 | $0 |
| Latigo Biotherapeutics, Inc. LTGO | Conversion | Aug 10, 2026 | Not reported |
| Latigo Biotherapeutics, Inc. LTGO | Conversion | Aug 10, 2026 | $0 |
| Latigo Biotherapeutics, Inc. LTGO | Conversion | Aug 10, 2026 | $0 |
| Latigo Biotherapeutics, Inc. LTGO | Conversion | Aug 10, 2026 | $0 |
| Latigo Biotherapeutics, Inc. LTGO | Conversion | Aug 10, 2026 | $0 |
| Latigo Biotherapeutics, Inc. LTGO | Conversion | Aug 10, 2026 | $0 |
| Latigo Biotherapeutics, Inc. LTGO | Conversion | Aug 10, 2026 | $0 |
| Latigo Biotherapeutics, Inc. LTGO Current | Conversion | Aug 10, 2026 | $0 |
| Latigo Biotherapeutics, Inc. LTGO | Conversion | Aug 10, 2026 | $0 |
| Latigo Biotherapeutics, Inc. LTGO | Conversion | Aug 10, 2026 | $0 |